Photonic nanojet‐mediated SERS technique for enhancing the Raman scattering of a few molecules

We report a two‐step enhancement of Raman scattering signal (η) of a few dye molecules. In the first step, high‐quality surface‐enhanced Raman scattering (SERS) substrates have been used. The SERS substrates were fabricated by direct current sputtering of Au followed by thermal annealing. The role of thermal annealing of the SERS substrates and numerical aperture of Raman microscopic objective lens on the enhancement has been studied for optimizing the enhancement in the SERS technique. In the second step, the value of η obtained with conventional SERS technique has been improved significantly with the help of photonic nanojet (PNJ) of an optical microsphere (PNJ‐mediated SERS technique). The signal to noise ratio and reproducibility of the experimental results have been found to be very high. Based on our theoretical simulations on PNJ, a few suitable parameters have been proposed for obtaining better enhancement using this technique. To the best of our belief, this report will enable the SERS community to improve η value with ease. Copyright © 2016 John Wiley & Sons, Ltd.     

核-壳型白藜芦醇分子印迹微球研制及应用

以表面修饰乙烯基团的SiO2微球为基体,白藜芦醇为模板分子,丙烯酰胺(AA)为功能单体,乙二醇二甲基丙烯酸酯(EGDMA)为交联剂,采用表面印迹技术制备核-壳型白藜芦醇印迹微球。采用红外光谱(IR)、扫描电子显微镜(SEM)对该分子印迹微球进行表征,结果表明,SiO2表面成功接枝一层厚度为200nm的印迹聚合物,该印迹微球颗粒分散均匀。采用高效液相色谱技术对印迹微球的吸附性进行研究表明,此印迹微球具有良好的识别性能,利用Scatchard模型分析得出印迹微球的最大吸附量分别为Qmax1=9.087mg/g和Qmax2=13.80mg/g。此印迹微球成功用于分离虎杖提取液中白藜芦醇。     

左旋甲基多巴分子印迹纳米给药系统的合成、表征及药物缓释研究

采用沉淀聚合法合成了左旋甲基多巴(L-Methyldopa, LMD)分子印迹聚合物微球(MIPMs), 并对其合成条件进行了详细研究. 结果表明, 聚合温度和引发剂的用量对微球的大小和形态有较大的影响, 微球的粒径随聚合温度的降低而增大, 随偶氮二异丁睛(AIBN)量的增大而增大. 而模板分子似乎对微球粒径的影响不是很明显. 通过扫描电镜、静态吸附试验(BET)和斯卡查德分析(Scatchard analysis)、红外光谱分析和模拟人体胃液扩散实验等对微球的外貌形态、吸附性能、分子印迹效果和药物缓释效果进行了表征. BET吸附实验和Scatchard 分析结果表明, 分子印迹聚合微球(MIPMs)的最大静态吸附量是非印迹聚合物微球(NIPMs)的3倍. 药物扩散实验表明, LMD在非印迹微球(NIPMs)上的释药率几乎与时间呈直线关系, 说明其释药过程完全受扩散控制; 而LMD在MIPMs上的释药率则呈曲线上升趋势, 说明其释药过程除了受扩散控制外, 还受到药物模板分子与MIPMs之间的印迹效应的协同作用的控制, 从而达到了缓释药物分子的目的. 实验结果表明, 在模拟胃液中, MIPMs释放药物的持续时间(10 h)是NIPMs持续时间(5 h)的2倍, 表明分子印迹微微球确实具有缓释药物的效果. 因此, MIPMs有望进一步应用于LMD药物缓释系统的研究.     

Preparation of cross-linked copolymer microspheres 4VP/St and cobalt tetraphenylporphyrins supported on it

The cross-linked microspheres 4VP/St made of 4-vinylpyridine (4VP) and styrene(St) were prepared with suspension copolymerization method using ethyl glycol dimethacylate (EGDMA) as cross-linker and polyvinyl alcohol (PVA) as disperser. The cobalt tetraphenylporphyrins (CoPs) were immobilized on 4VP/St microspheres via the axial coordination reaction between CoPs and the pyridine groups of 4VP/St microspheres, resulting in the functional microspheres CoP-4VP/St. The chemical structure of 4VP/St and CoP-4VP/St were characterized with infrared spectrum and their morphologies were observed with the scanning electron microscope. The experimental results show that via controlling the various reaction conditions of the suspension copolymerization, the 4VP/St microspheres with excellent sphericity and narrow particle diameter distribution can be gained. In addition, CoPs are successfully immobilized on 4VP/St microspheres by means of Co-N bonds, on which the immobilized content of CoPs goes up to 10.7-17.5 μmol/g.     

Fabrication of a new electrochemiluminescent sensor for fentanyl citrate based on glassy carbon microspheres and ionic liquid composite paste electrode

Due to the high performance of glassy carbon in the aspects of mechanical strength, electrical conductivity and high corrosion resistance, etc., glassy carbon has been widely used in the electrochemistry. A new form of glassy carbon, glassy carbon microsphere, was utilized to couple with ionic liquid in preparing a new electrochemiluminescent platform for Ru(bpy)₃Cl₂. Room temperature ionic liquid has been proposed to be very interesting and efficient pasting binder to replace the non conductive organic binders for the fabrication of composite paste electrode. Attributed to the special characteristics of glassy carbon microspheres and room temperature ionic liquid [N-octylpyridium tetrafluoroborate (OPFP)], this new electrochemiluminescent sensor exhibited excellent electrochemiluminescent performance in Ru(bpy)₃²⁺ solution. We first found that fentanyl citrate could increase the ECL of Ru(bpy)₃²⁺, hence an ECL approach was developed for the determination of fentanyl citrate based on this glassy carbon microspheres based electrochemiluminescent platform with high sensitivity. Under the optimized conditions, the enhanced electrochemiluminescent intensity versus fentanyl citrate concentration was linear in the range of 1.0 × 10⁻⁸ to 1.0 × 10⁻⁴ mol L⁻¹ with a detection limit of 8.5 × 10⁻⁹ mol L⁻¹, and the relative standard deviation for 1.0 × 10⁻⁶ mol L⁻¹ fentanyl citrate was 1.90% (n = 10). This protocol has extended the application scopes of glassy carbon material and promoted the application of glassy carbon microspheres in electroanalysis.     

壳聚糖丝心蛋白包药微球的结构和释放性能研究

近年,高分子微球的研究与开发十分引人注目.将药物包裹于微球中,经主动和被动控制,进入预定靶器官或组织后缓慢释放出,不仅可降低其毒副作用,还可提高其生物活性利用度,壳聚糖(ＣＳ)可作牛血清白蛋白等药物缓释微球的载体[1～3].丝心蛋白(ＦＢ)含18种氨基酸,具有多孔性和良好的渗透性[4],也是一种理想的生物材料.壳聚糖和丝心蛋白共混可交联成半互穿聚合物网络(ＳｅｍｉＩＰＮ)结构.具有智能水凝胶的性能[5].本实验室已用纤维素铜氨液分别与干酪素、海藻酸钠及魔芋共混制得共混膜,两种分子间存在由次价键力引起的很强的相互作用,使其力学性…     

Morphology of poly(p‐oxybenzoyl) prepared in perfluoropolyether

Solvent effect on the morphology of poly(p‐oxybenzoyl) (POB) prepared by the reaction‐induced phase separation of oligomers was examined by the polymerization of p‐acetoxybenzoic acid in perfluoropolyether Aflunox^TM (AFL2507 and AFL606). Polymerization was carried out at 320°C for 6 hr. POB microspheres were formed in AFL2507 by the liquid–liquid phase separation of oligomers due to the low miscibility of oligomers in AFL2507. The molecular weight of the solvent influenced the morphology, and the polymerization in AFL606 of which the molecular weight was lower than AFL2507 yielded whiskers formed by crystallization of oligomers induced by the increase in miscibility compared with that in AFL2507. The solvent structure and its molecular weight influenced the miscibility of oligomers and ultimately controlled the morphology from whisker to microsphere. Copyright © 2004 John Wiley & Sons, Ltd.     

具有光导性的磁性高分子微球——反应性铁酞菁与苯乙烯共聚

合成出了带有反应性基团的铁酞菁单体 ,并实现了与苯乙烯单体在磁流体存在下的分散聚合而得磁性高分子微球 .研究了微球结构、组成 ,测定了其磁响应性和光导性     

Specific hemoperfusion through agarose acrobeads

Agarose acrobeads were produced by encapsulating polyacrolein microspheres (acrobeads) of 0.2 μm average diameter within an agarose matrix. Crosslinked agarose acrobeads of diameters ranging from 0.5 to 0.8 mm were found to be optimal spheres for specific hemoperfusion purposes. Agarose provides the biocompatibility and mechanical strength of the agarose acrobeads. Acrobeads contain a high aldehyde-group content through which various amino ligands, i.e., proteins, antigens, antibodies, enzymes, and so on, can be covalently bound in a single step under physiological pH (or other pH). Thus, antibodies, antigens, or toxic materials may be directly removed from whole blood by hemoperfusion. During in vitro and in vivo hemoperfusion trials, the content of erythrocytes, leukocytes, and thrombocytes was essentially unaltered. Likewise, a battery of the soluble blood components (Cl^-, K⁺, Na⁺, Ca²⁺, PO ₄ ^- ), total proteins, albumin, and C ₄ ^′ component of the complement cascade, as well as the enzymes SGOT, LDH, and alkaline phosphatase, remained constant within narrow limits during the hemoperfusion procedure. The chemical and physical structure of the beads is stable; neither acrolein nor bead fragments were detected in hemoperfusion trials. Similarly, leakage of antibody bound to the agarose acrobeads into the blood is insignificant. Thus far, we have demonstrated the efficacy of the crosslinked agarose acrobeads for extracorporeal removal of “unwanted” substances from whole blood in the following systems: (a) removal of specific antigens (digoxin or paraquat removal with antidigoxin or antiparaquat antibodies bound to the acrobeads, respectively), (b) removal of specific antibody (antiBSA) removal with BSA bound to the beads), (c) removal of immune complexes (BSA-antiBSA complex removal with C1q bound to acrobeads), and (d) removal of specific metals (removal of iron with deferoxamine bound to the agarose acrobeads).     

纳米晶粒TiO2多孔微球的合成与表征

 钛酸四丁酯经酸性水解得到TiO2溶胶，将溶胶与苯酚混合后加入到正庚烷分散介质中，再滴加甲醛水溶液，通过反相悬浮聚合和溶胶－凝胶过程制备了聚合物与TiO2的复合微球．对复合微球进行焙烧处理，使聚合物分解，从而得到由纳米TiO2晶粒组成的多孔微球．以示差扫描量热法、热重分析、X射线衍射、扫描电子显微镜和氮吸附等方法对TiO2多孔微球的物理性质进行了表征．结果表明，所得TiO2多孔微球主要由锐钛型TiO2纳米晶粒组成，晶粒尺寸为20～30nm；TiO2多孔微球的直径为200～500μm，比表面积为87．40m2／g，平均孔径为8．65nm，孔径的分布具有单分散特征．